Advertisement

Clinical Rheumatology

, Volume 37, Issue 10, pp 2685–2692 | Cite as

Serum 25-hydroxyvitamin D3 levels and flares of systemic lupus erythematosus: a longitudinal cohort analysis

  • Chi Chiu MokEmail author
  • Eric T. Bro
  • Ling Yin Ho
  • Ravinder J. Singh
  • Paul J. Jannetto
Original Article

Abstract

The aim of this study is to evaluate the relationship between baseline serum 25-hydroxyvitamin D3 levels and SLE activity/flares over time. This is a longitudinal study of 276 patients who fulfilled ≥ 4 ACR criteria for SLE and recruited in the year 2011. Serum samples were collected at baseline and assayed for 25-hydroxyvitamin D3 at the end of a mean follow-up of 32.5 months. Participants were stratified into three groups according to baseline 25-hydroxyvitamin D3 levels: group I (< 15 ng/ml, deficiency), group II (15–30 ng/ml, insufficiency), and group III (> 30 ng/ml, adequate). Baseline and summated SLE disease activity index (SLEDAI) score over time and the annual incidence of lupus flares were compared among these groups. 25-hydroxyvitamin D3 levels of < 15, 15–30, and > 30 ng/ml were present in 26, 54, and 20% of the recruited patients, respectively. Group I had significantly higher baseline SLEDAI scores. After a follow-up of 32.5 ± 5.5 months, 153 mild/moderate and 91 severe flares developed. The mean summated SLEDAI was 3.2 ± 2.0 in group I, 2.4 ± 1.9 in group II and 2.7 ± 2.1 in group III patients (P = 0.02). The annual incidence of mild/moderate and severe flares was 0.26 ± 0.39 and 0.20 ± 0.45 (group I); 0.20 ± 0.33 and 0.09 ± 0.22 (group II); and 0.20 ± 0.32 and 0.14 ± 0.46 (group III), respectively (P > 0.05). In a subgroup of 73 patients who were clinically and serologically quiescent at baseline, a similar trend of more flares was observed in group I patients. Vitamin D deficiency was frequent in Chinese SLE patients and was associated with more active disease at baseline and over time, as well as a trend of more severe lupus flares.

Keywords

Cholecalciferol Damage Disease activity Flares Vitamin D 

Notes

Grant support

None

Author contribution

All the authors have contributed substantially to this work.

Compliance with ethical standards

Ethics and consent

Written consent was obtained from all the participants, and this study was approved by the Ethics Committee of our hospital.

Disclosures

None.

References

  1. 1.
    Mok CC (2014) Emerging biological therapies for systemic lupus erythematosus. Expert Opin Emerg Drugs 19:303–322CrossRefPubMedGoogle Scholar
  2. 2.
    Mok CC (2013) Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin Immunol 9:453–463CrossRefPubMedGoogle Scholar
  3. 3.
    Gatenby P, Lucas R, Swaminathan A (2013) Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol 25:184–191CrossRefPubMedGoogle Scholar
  4. 4.
    Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117CrossRefPubMedGoogle Scholar
  5. 5.
    Ritterhouse LL, Crowe SR, Niewold TB, Merrill JT, Roberts VC, Dedeke AB et al (2011) Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 70:1569–1574CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH (2012) Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) 51:644–652CrossRefGoogle Scholar
  7. 7.
    Sumethkul K, Boonyaratavej S, Kitumnuaypong T, Angthararuk S, Cheewasat P, Manadee N, Sumethkul V (2013) The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int 33:1461–1467CrossRefPubMedGoogle Scholar
  8. 8.
    Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T et al (2010) Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 69:1155–1157CrossRefPubMedGoogle Scholar
  9. 9.
    Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E (2011) The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol 40:122–126CrossRefPubMedGoogle Scholar
  10. 10.
    Wu PW, Rhew EY, Dyer AR, Dunlop DD, Langman CB, Price H, Sutton-Tyrrell K, McPherson DD, Edmundowicz D, Kondos GT, Ramsey-Goldman R (2009) 25-Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 61:1387–1395CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Gao CC, Liu SY, Wu ZZ, Li TF, Gao GM, Liu ZS, Zheng ZH (2016) Severe vitamin D deficiency increases the risk for moderate to severe disease activity in Chinese patients with SLE. Lupus 25:1224–1229CrossRefPubMedGoogle Scholar
  12. 12.
    Yap KS, Northcott M, Hoi AB, Morand EF, Nikpour M (2015) Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. Lupus Sci Med 2:e000064CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Mandal M, Tripathy R, Panda AK, Pattanaik SS, Dakua S, Pradhan AK, Chakraborty S, Ravindran B, Das BK (2014) Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha. Arthritis Res Ther 16:R49CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMedGoogle Scholar
  15. 15.
    Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, Merrill JT, Sammaritano L, Lockshin M, Alarcón GS, Manzi S, Belmont HM, Askanase AD, Sigler L, Dooley MA, von Feldt J, McCune WJ, Friedman A, Wachs J, Cronin M, Hearth-Holmes M, Tan M, Licciardi F (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142:953–962CrossRefPubMedGoogle Scholar
  16. 16.
    Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune W, Hearth-Holmes M, Dooley MA, von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP, OC-SELENA Trial (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353:2550–2558CrossRefPubMedGoogle Scholar
  17. 17.
    Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369CrossRefPubMedGoogle Scholar
  18. 18.
    Adams JS, Hewison M (2010) Update in vitamin D. J Clin Endocrinol Metab 95:471–478CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin N Am 39:365–379CrossRefGoogle Scholar
  20. 20.
    Yang CY, Leung PS, Adamopoulos IE, Gershwin ME (2013) The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol 45:217–226CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139–145CrossRefPubMedGoogle Scholar
  22. 22.
    Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179:1634–1647CrossRefPubMedGoogle Scholar
  23. 23.
    Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) Vitamin D: modulator of the immune system. Curr Opin Pharmacol 10:482–496CrossRefPubMedGoogle Scholar
  24. 24.
    Yu S, Cantorna MT (2008) The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A 105:5207–5212CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, Butcher EC (2007) DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8:285–293CrossRefPubMedGoogle Scholar
  26. 26.
    Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH (2012) Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus 21:36–42CrossRefPubMedGoogle Scholar
  27. 27.
    Birmingham DJ, Hebert LA, Song H, Noonan WT, Rovin BH, Nagaraja HN, Yu CY (2012) Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 21:855–864CrossRefPubMedGoogle Scholar
  28. 28.
    Dall'Ara F, Andreoli L, Piva N, Piantoni S, Franceschini F, Tincani A (2015) Winter lupus flares are associated with low vitamin D levels in a retrospective longitudinal study of Italian adult patients. Clin Exp Rheumatol 33:153–158PubMedGoogle Scholar
  29. 29.
    Petri M, Bello KJ, Fang H, Magder LS (2013) Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum 65:1865–1871CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Schoindre Y, Jallouli M, Tanguy ML, Ghillani P, Galicier L, Aumaître O et al (2014) Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up. Lupus Sci Med 1:e000027CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Abou-Raya A, Abou-Raya S, Helmii M (2013) The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 40:265–272CrossRefPubMedGoogle Scholar
  32. 32.
    Lima GL, Paupitz J, Aikawa NE, Takayama L, Bonfa E, Pereira RM (2016) Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res (Hoboken) 68:91–98CrossRefGoogle Scholar
  33. 33.
    Aranow C, Kamen DL, Dall'Era M, Massarotti EM, Mackay MC, Koumpouras F, Coca A, Chatham WW, Clowse MEB, Criscione-Schreiber LG, Callahan S, Goldmuntz EA, Keyes-Elstein L, Oswald M, Gregersen PK, Diamond B (2015) Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus. Arthritis Rheumatol 67:1848–1857CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Andreoli L, Dall'Ara F, Piantoni S, Zanola A, Piva N, Cutolo M et al (2015) A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus. Lupus 24:499–506CrossRefPubMedGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2018

Authors and Affiliations

  • Chi Chiu Mok
    • 1
    Email author
  • Eric T. Bro
    • 2
  • Ling Yin Ho
    • 1
  • Ravinder J. Singh
    • 2
  • Paul J. Jannetto
    • 2
  1. 1.Department of MedicineTuen Mun HospitalHong KongChina
  2. 2.Department of Laboratory Medicine and PathologyMayo ClinicRochesterUSA

Personalised recommendations